Cargando…

B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil

The generation of high-affinity antibodies requires somatic hypermutation (SHM) and class switch recombination (CSR) at the immunoglobulin (Ig) locus. Both processes are triggered by activation-induced cytidine deaminase (AID) and require UNG-encoded uracil-DNA glycosylase. AID has been suggested to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kavli, Bodil, Andersen, Sonja, Otterlei, Marit, Liabakk, Nina B., Imai, Kohsuke, Fischer, Alain, Durandy, Anne, Krokan, Hans E., Slupphaug, Geir
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212036/
https://www.ncbi.nlm.nih.gov/pubmed/15967827
http://dx.doi.org/10.1084/jem.20050042
_version_ 1782148609089732608
author Kavli, Bodil
Andersen, Sonja
Otterlei, Marit
Liabakk, Nina B.
Imai, Kohsuke
Fischer, Alain
Durandy, Anne
Krokan, Hans E.
Slupphaug, Geir
author_facet Kavli, Bodil
Andersen, Sonja
Otterlei, Marit
Liabakk, Nina B.
Imai, Kohsuke
Fischer, Alain
Durandy, Anne
Krokan, Hans E.
Slupphaug, Geir
author_sort Kavli, Bodil
collection PubMed
description The generation of high-affinity antibodies requires somatic hypermutation (SHM) and class switch recombination (CSR) at the immunoglobulin (Ig) locus. Both processes are triggered by activation-induced cytidine deaminase (AID) and require UNG-encoded uracil-DNA glycosylase. AID has been suggested to function as an mRNA editing deaminase or as a single-strand DNA deaminase. In the latter model, SHM may result from replicative incorporation of dAMP opposite U or from error-prone repair of U, whereas CSR may be triggered by strand breaks at abasic sites. Here, we demonstrate that extracts of UNG-proficient human B cell lines efficiently remove U from single-stranded DNA. In B cell lines from hyper-IgM patients carrying UNG mutations, the single-strand–specific uracil-DNA glycosylase, SMUG1, cannot complement this function. Moreover, the UNG mutations lead to increased accumulation of genomic uracil. One mutation results in an F251S substitution in the UNG catalytic domain. Although this UNG form was fully active and stable when expressed in Escherichia coli, it was mistargeted to mitochondria and degraded in mammalian cells. Our results may explain why SMUG1 cannot compensate the UNG2 deficiency in human B cells, and are fully consistent with the DNA deamination model that requires active nuclear UNG2. Based on our findings and recent information in the literature, we present an integrated model for the initiating steps in CSR.
format Text
id pubmed-2212036
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-22120362008-03-11 B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil Kavli, Bodil Andersen, Sonja Otterlei, Marit Liabakk, Nina B. Imai, Kohsuke Fischer, Alain Durandy, Anne Krokan, Hans E. Slupphaug, Geir J Exp Med Article The generation of high-affinity antibodies requires somatic hypermutation (SHM) and class switch recombination (CSR) at the immunoglobulin (Ig) locus. Both processes are triggered by activation-induced cytidine deaminase (AID) and require UNG-encoded uracil-DNA glycosylase. AID has been suggested to function as an mRNA editing deaminase or as a single-strand DNA deaminase. In the latter model, SHM may result from replicative incorporation of dAMP opposite U or from error-prone repair of U, whereas CSR may be triggered by strand breaks at abasic sites. Here, we demonstrate that extracts of UNG-proficient human B cell lines efficiently remove U from single-stranded DNA. In B cell lines from hyper-IgM patients carrying UNG mutations, the single-strand–specific uracil-DNA glycosylase, SMUG1, cannot complement this function. Moreover, the UNG mutations lead to increased accumulation of genomic uracil. One mutation results in an F251S substitution in the UNG catalytic domain. Although this UNG form was fully active and stable when expressed in Escherichia coli, it was mistargeted to mitochondria and degraded in mammalian cells. Our results may explain why SMUG1 cannot compensate the UNG2 deficiency in human B cells, and are fully consistent with the DNA deamination model that requires active nuclear UNG2. Based on our findings and recent information in the literature, we present an integrated model for the initiating steps in CSR. The Rockefeller University Press 2005-06-20 /pmc/articles/PMC2212036/ /pubmed/15967827 http://dx.doi.org/10.1084/jem.20050042 Text en Copyright © 2005, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Kavli, Bodil
Andersen, Sonja
Otterlei, Marit
Liabakk, Nina B.
Imai, Kohsuke
Fischer, Alain
Durandy, Anne
Krokan, Hans E.
Slupphaug, Geir
B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil
title B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil
title_full B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil
title_fullStr B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil
title_full_unstemmed B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil
title_short B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil
title_sort b cells from hyper-igm patients carrying ung mutations lack ability to remove uracil from ssdna and have elevated genomic uracil
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212036/
https://www.ncbi.nlm.nih.gov/pubmed/15967827
http://dx.doi.org/10.1084/jem.20050042
work_keys_str_mv AT kavlibodil bcellsfromhyperigmpatientscarryingungmutationslackabilitytoremoveuracilfromssdnaandhaveelevatedgenomicuracil
AT andersensonja bcellsfromhyperigmpatientscarryingungmutationslackabilitytoremoveuracilfromssdnaandhaveelevatedgenomicuracil
AT otterleimarit bcellsfromhyperigmpatientscarryingungmutationslackabilitytoremoveuracilfromssdnaandhaveelevatedgenomicuracil
AT liabakkninab bcellsfromhyperigmpatientscarryingungmutationslackabilitytoremoveuracilfromssdnaandhaveelevatedgenomicuracil
AT imaikohsuke bcellsfromhyperigmpatientscarryingungmutationslackabilitytoremoveuracilfromssdnaandhaveelevatedgenomicuracil
AT fischeralain bcellsfromhyperigmpatientscarryingungmutationslackabilitytoremoveuracilfromssdnaandhaveelevatedgenomicuracil
AT durandyanne bcellsfromhyperigmpatientscarryingungmutationslackabilitytoremoveuracilfromssdnaandhaveelevatedgenomicuracil
AT krokanhanse bcellsfromhyperigmpatientscarryingungmutationslackabilitytoremoveuracilfromssdnaandhaveelevatedgenomicuracil
AT slupphauggeir bcellsfromhyperigmpatientscarryingungmutationslackabilitytoremoveuracilfromssdnaandhaveelevatedgenomicuracil